SCHEMBL30612045

SCHEMBL30612045

COC(=O)c1cc(Cl)nc2c1ccn2CCS(C)(=O)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.46
▸ ADCY10 Q96PN6 1/20 0.37
▸ ALDH1A1 P00352 8/20 0.34
▸ MAPT P10636 3/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ PLA2G2A P14555 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ GLA P06280 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26108500 1.00 KDM4E (0.46) KDM4EADCY10ALDH1A1MAPTSMN1; SMN2
SCHEMBL30611894 0.83 KDM4E (0.52) KDM4EADCY10ALDH1A1MAPTSMN1; SMN2
SCHEMBL26107710 0.83 KDM4E (0.52) KDM4EADCY10ALDH1A1MAPTSMN1; SMN2
SCHEMBL26105230 0.80 KDM4E (0.49) KDM4EADCY10ALDH1A1MAPTSMN1; SMN2
SCHEMBL31347186 0.80 KDM4E (0.49) KDM4EADCY10ALDH1A1MAPTSMN1; SMN2
SCHEMBL31347137 0.79 KDM4E (0.48) KDM4EADCY10ALDH1A1MAPTSMN1; SMN2
SCHEMBL31347211 0.79 KDM4E (0.57) KDM4EALDH1A1MAPTPLA2G2APOLB
SCHEMBL30611844 0.79 KDM4E (0.48) KDM4EADCY10ALDH1A1MAPTSMN1; SMN2
SCHEMBL30612114 0.79 KDM4E (0.48) KDM4EADCY10ALDH1A1MAPTSMN1; SMN2
SCHEMBL26105877 0.79 KDM4E (0.48) KDM4EADCY10ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585252-A Bicyclic heteroaryl containing compounds as IKZF2 degrading agents 翁科皮亚治疗公司和SK生命科学实验室 2025-03-07 — — CN disclosed
EP-4499629-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs (US) 2025-02-05 — — EP disclosed
WO-2023183919-A1 BICYCLIC HETEROARYL-CONTAINING COMPOUNDS AS IKZF2 DEGRADERS ONCOPIA THERAPEUTICS, INC. D/B/A PROTEOVANT THERAPEUTICS, INC. (US) 2023-09-28 — — WO disclosed
Send feedback